analysis of controlled studies performed by the polycythemia vera study group ( p.v.s.g . ) and the european organization for research in treatment of cancer ( e.o.r.t.c . ) indicate that busulphan ( myleran ) ( bu ) is the treatment of choice for polycythemia vera ( pv ) .
C0006463
bu
C0032463
polycythemia vera